NVIDIA (NVDA) PT Raised to $169 at Truist Securities

Truist Securities analyst William Stein raised the price target on NVIDIA (NASDAQ: NVDA) to $169.00 (from $167.00) while maintaining a Buy rating.

The analyst comments: "Despite technical concerns about its next-gen GPU, and some near-term GPM pressure, NVDA delivered an overall strong Q3 result & Q4 guide. NVDA's increased confidence in the Blackwell ramp should overwhelm the drag on the stock from a Q4 revenue guidance number that was just 'good' rather than 'great'. NVDA remains the AI company owing to its culture of innovation, ecosystem of incumbency, and massive investment in software, pre-trained models, and services. CY25 EPS goes to $4.22 (from $4.18). PT to $169 (from $167) based on 40x EPS (historical 5x discount to hi-growth semi peers)."

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink
• UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen